Procyon Advisors’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$248K Sell
1,180
-132
-10% -$28.3K 0.01% 503
2026
Q1
$290K Buy
1,312
+493
+60% +$121K 0.01% 471
2025
Q4
$208K Sell
819
-72
-8% -$18.1K 0.01% 523
2025
Q3
$220K Buy
891
+50
+6% +$12K 0.01% 461
2025
Q2
$202K Buy
+841
New +$196K 0.02% 451
2020
Q3
Sell
-63
Closed -$10K 944
2020
Q2
$10K Buy
63
+45
+250% +$6.86K 0.01% 661
2020
Q1
$3K Sell
18
-48
-73% -$7.18K ﹤0.01% 816
2019
Q4
$10K Buy
+66
New +$9.67K 0.01% 662

Other funds holding STE

Procyon Advisors's STE Position: Q2 2026 in Review

Procyon Advisors reduced its Steris (STE) stake by 10% in Q2 2026, selling an estimated $28.3K and leaving 1,180 shares worth $248K. The position accounts for 0.01% of the portfolio, ranked #503.

Procyon Advisors first reported a position in STE in Q4 2019 and has held it in 8 quarters since. The position peaked at $290K in Q1 2026. 830 funds tracked by Wall St. Rank hold STE as of Q2 2026.

  • Procyon Advisors held 1,180 shares of Steris worth $248K as of Q2 2026.
  • Procyon Advisors sold 132 Steris shares in Q2 2026, an estimated $28.3K.
  • Steris made up 0.01% of Procyon Advisors's portfolio in Q2 2026, its #503 holding.
  • Procyon Advisors first reported a position in Steris in Q4 2019 and has held it in 8 quarters since.
  • Procyon Advisors's Steris position peaked at $290K in Q1 2026.
  • 830 funds tracked by Wall St. Rank held Steris as of Q2 2026.

Based on Procyon Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.